Sum composition results

AbbreviationFormulaMassMain ClassSub Class
Galα1-3Galβ1-4Glcβ-Cer(d34:1)C52H97NO181023.670570Neutral glycosphingolipids [SP05]Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
Galα1-3Galβ1-4Glcβ-Cer(d36:1)C54H101NO181051.701871Neutral glycosphingolipids [SP05]Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
Galα1-3Galβ1-4Glcβ-Cer(d38:1)C56H105NO181079.733171Neutral glycosphingolipids [SP05]Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
Galα1-3Galβ1-4Glcβ-Cer(d40:1)C58H109NO181107.764471Neutral glycosphingolipids [SP05]Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
Galα1-3Galβ1-4Glcβ-Cer(d42:2)C60H111NO181133.780121Neutral glycosphingolipids [SP05]Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
Galα1-3Galβ1-4Glcβ-Cer(d42:1)C60H113NO181135.795771Neutral glycosphingolipids [SP05]Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
Galα1-3Galβ1-4Glcβ-Cer(d44:2)C62H115NO181161.811421Neutral glycosphingolipids [SP05]Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
Galα1-3Galβ1-4Glcβ-Cer(d44:1)C62H117NO181163.827071Neutral glycosphingolipids [SP05]Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
Galα1-3(Fucα1-2)Galβ1-4Glcβ-Cer(d34:1)C58H107NO221169.728481Neutral glycosphingolipids [SP05]Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
Galα1-3Galα1-3Galβ1-4Glcβ-Cer(d34:1)C58H107NO231185.723396Neutral glycosphingolipids [SP05]Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
Galα1-3(Fucα1-2)Galβ1-4Glcβ-Cer(d36:1)C60H111NO221197.759781Neutral glycosphingolipids [SP05]Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
Galα1-3Galα1-3Galβ1-4Glcβ-Cer(d36:1)C60H111NO231213.754696Neutral glycosphingolipids [SP05]Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
Galα1-3(Fucα1-2)Galβ1-4Glcβ-Cer(d38:1)C62H115NO221225.791081Neutral glycosphingolipids [SP05]Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
Galα1-3(GalNAcβ1-4)Galβ1-4Glcβ-Cer(d34:1)C60H110N2O231226.749944Neutral glycosphingolipids [SP05]Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
Galβ1-4GlcNAcβ1-3Galβ1-4Glcβ-Cer(d34:1)C60H110N2O231226.749944Neutral glycosphingolipids [SP05]Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
GalNAcβ1-3Galα1-3Galβ1-4Glcβ-Cer(d34:1)C60H110N2O231226.749944Neutral glycosphingolipids [SP05]Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
GlcNAcβ1-3Galα1-3Galβ1-4Glcβ-Cer(d34:1)C60H110N2O231226.749944Neutral glycosphingolipids [SP05]Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
Galα1-3Galα1-3Galβ1-4Glcβ-Cer(d38:1)C62H115NO231241.785996Neutral glycosphingolipids [SP05]Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
Galα1-3(Fucα1-2)Galβ1-4Glcβ-Cer(d40:1)C64H119NO221253.822381Neutral glycosphingolipids [SP05]Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
Galα1-3(GalNAcβ1-4)Galβ1-4Glcβ-Cer(d36:1)C62H114N2O231254.781245Neutral glycosphingolipids [SP05]Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
Galβ1-4GlcNAcβ1-3Galβ1-4Glcβ-Cer(d36:1)C62H114N2O231254.781245Neutral glycosphingolipids [SP05]Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
GalNAcβ1-3Galα1-3Galβ1-4Glcβ-Cer(d36:1)C62H114N2O231254.781245Neutral glycosphingolipids [SP05]Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
GlcNAcβ1-3Galα1-3Galβ1-4Glcβ-Cer(d36:1)C62H114N2O231254.781245Neutral glycosphingolipids [SP05]Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
Galα1-3Galα1-3Galβ1-4Glcβ-Cer(d40:1)C64H119NO231269.817296Neutral glycosphingolipids [SP05]Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
Galα1-3(Fucα1-2)Galβ1-4Glcβ-Cer(d42:2)C66H121NO221279.838031Neutral glycosphingolipids [SP05]Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
Galα1-3(Fucα1-2)Galβ1-4Glcβ-Cer(d42:1)C66H123NO221281.853681Neutral glycosphingolipids [SP05]Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
Galα1-3(GalNAcβ1-4)Galβ1-4Glcβ-Cer(d38:1)C64H118N2O231282.812545Neutral glycosphingolipids [SP05]Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
Galβ1-4GlcNAcβ1-3Galβ1-4Glcβ-Cer(d38:1)C64H118N2O231282.812545Neutral glycosphingolipids [SP05]Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
GalNAcβ1-3Galα1-3Galβ1-4Glcβ-Cer(d38:1)C64H118N2O231282.812545Neutral glycosphingolipids [SP05]Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
GlcNAcβ1-3Galα1-3Galβ1-4Glcβ-Cer(d38:1)C64H118N2O231282.812545Neutral glycosphingolipids [SP05]Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
Galα1-3Galα1-3Galβ1-4Glcβ-Cer(d42:2)C66H121NO231295.832946Neutral glycosphingolipids [SP05]Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
Galα1-3Galα1-3Galβ1-4Glcβ-Cer(d42:1)C66H123NO231297.848596Neutral glycosphingolipids [SP05]Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
Galα1-3(Fucα1-2)Galβ1-4Glcβ-Cer(d44:2)C68H125NO221307.869331Neutral glycosphingolipids [SP05]Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
Galα1-3(Fucα1-2)Galβ1-4Glcβ-Cer(d44:1)C68H127NO221309.884981Neutral glycosphingolipids [SP05]Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
Galα1-3(GalNAcβ1-4)Galβ1-4Glcβ-Cer(d40:1)C66H122N2O231310.843845Neutral glycosphingolipids [SP05]Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
Galβ1-4GlcNAcβ1-3Galβ1-4Glcβ-Cer(d40:1)C66H122N2O231310.843845Neutral glycosphingolipids [SP05]Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
GalNAcβ1-3Galα1-3Galβ1-4Glcβ-Cer(d40:1)C66H122N2O231310.843845Neutral glycosphingolipids [SP05]Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
GlcNAcβ1-3Galα1-3Galβ1-4Glcβ-Cer(d40:1)C66H122N2O231310.843845Neutral glycosphingolipids [SP05]Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
Galα1-3Galα1-3Galβ1-4Glcβ-Cer(d44:2)C68H125NO231323.864246Neutral glycosphingolipids [SP05]Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
Galα1-3Galα1-3Galβ1-4Glcβ-Cer(d44:1)C68H127NO231325.879896Neutral glycosphingolipids [SP05]Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
Galα1-3(GalNAcβ1-4)Galβ1-4Glcβ-Cer(d42:2)C68H124N2O231336.859495Neutral glycosphingolipids [SP05]Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
Galβ1-4GlcNAcβ1-3Galβ1-4Glcβ-Cer(d42:2)C68H124N2O231336.859495Neutral glycosphingolipids [SP05]Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
GalNAcβ1-3Galα1-3Galβ1-4Glcβ-Cer(d42:2)C68H124N2O231336.859495Neutral glycosphingolipids [SP05]Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
GlcNAcβ1-3Galα1-3Galβ1-4Glcβ-Cer(d42:2)C68H124N2O231336.859495Neutral glycosphingolipids [SP05]Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
Galα1-3(GalNAcβ1-4)Galβ1-4Glcβ-Cer(d42:1)C68H126N2O231338.875145Neutral glycosphingolipids [SP05]Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
Galβ1-4GlcNAcβ1-3Galβ1-4Glcβ-Cer(d42:1)C68H126N2O231338.875145Neutral glycosphingolipids [SP05]Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
GalNAcβ1-3Galα1-3Galβ1-4Glcβ-Cer(d42:1)C68H126N2O231338.875145Neutral glycosphingolipids [SP05]Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
GlcNAcβ1-3Galα1-3Galβ1-4Glcβ-Cer(d42:1)C68H126N2O231338.875145Neutral glycosphingolipids [SP05]Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
Galα1-3(GalNAcβ1-4)Galβ1-4Glcβ-Cer(d44:2)C70H128N2O231364.890795Neutral glycosphingolipids [SP05]Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
Galβ1-4GlcNAcβ1-3Galβ1-4Glcβ-Cer(d44:2)C70H128N2O231364.890795Neutral glycosphingolipids [SP05]Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]

Showing page 1 of 18     Results:    1  2  3  4  5  Next  Last     Showing results 1 to 50 of 880